Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2022-12-19 11:05:22）
  Otsuki Taiichiro
   Department   Specialty Division  , Clinical Medicine Seminars
   Specialty Division  Thoracic Oncology, Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. 2013/09
2. Original article　 [Environmental air pollutants and the risk of cancer]. 2013/11
3. Original article　 Biallelic germline and somatic mutations in malignant mesothelioma: Multiple mutations in transcription regulators including mSWI/SNF genes. 2015/02
4. Original article　 A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS(regimen, PS, histology or stage) index 2015/04
5. Original article　 Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients 2015/06
6. Original article　 Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case. 2015/09
7. Case report　 Consideration regarding immune checkpoint inhibitor-induced secondary adrenal insufficiency in patients lacking human leucocyte antigen-DR15 2021/01
Display 5 items
Display all(7)
■ Presentation
1. AMP Converted from Intracelluarly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis  2013/10/29
2. A new prognostic index for overall survival in malignant pleural mesothelioma
-PHS index  2014/09/27
3. Rare germline variants of transcription regulator genes in malignant mesothelioma  2014/09/27
4. Clinical role of pleural effusion ADA levels in malignant pleural mesothelioma  2014/10/22
5. Newly synthesized anticancer agent HUHS1015(naftopidil analogue) is effective for malignant pleural mesothelioma(MPM).  2014/10/22
6. Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma  2014/10/22
7. Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma  2015/09/07
8. Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015,Preclinical Evidence for Treatment.  2015/09/08
9. Naftopidil Is Effective in the Treatment of Malignant Pleural Mesothelioma.  2015/09/09
10. NF2 mutations in malignant pleural mesothelioma synchronous with acoustic neuroma:disease-causing mutation or chance effect?  2015/09/09
11. A report on three cases of intramuscular metastasis from malignant pleural mesothelioma  2015/12/20
12. Examination of the serum soluble mesothelin-related peptide (SMRP) level in patients with malignant pleural mesothelioma  2016/05/02
13. Patterns of Detectable Tumor Progression in Patients with Malignant Pleural Mesothelioma with an FDG-PET-Negative T1a Tumor  2016/05/02
14. Relationship between Histological Type and Pleural Mesothelioma  2016/05/02
15. Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma  2016/05/03
16. The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma  2016/05/03
17. PET/CT FOR PATIENTS WITH VERY EARLY CLINICAL STAGE OF MALIGNANT PLEURAL MESOTHELIOMA:WHEN CAT PET/CT DETECT TUMOR GROWTH OF TO/T1A MESOTHLIOMA?  2016/12/06
18. between the stainability of the neurofibromatosis type 2 gene-related protein merlin and the tumor properties of mesotheliomas  2016/12/07
19. Mesothelium Covering Pleural Plaque Is Not Primary Involved in Asbestos-Induced Mesothelial Carcinogenesis in Human  2016/12/07
20. Cisplatin in Combination for Pemetrexed in the Treatment of Patients with Advanced Malignant Peritoneal Mesothelioma -Retrospective study of 24 cases  2016/12/16
21. Two cases of pembrolizumab-induced secondary adrenal insufficiency  2021/03/20
Display 5 items
Display all(21)
mail